Increasing Prevalence of FBS Coupled with Large Patient Pool Estimated to Influence the Growth of the UK Neural Implants Market

The UK neural implants market is expected to exhibit a rapid CAGR of 7.8% during the forecast period (2021-2027). In the UK, it is estimated that approximately 10–40% of individuals undergoing back surgery suffer from FBS. An estimated prevalence of FBS for neuropathic back and leg pain was around 5,800 per 100,000 population in the country. As a result, the NHS recommends such patients to undergo SCS procedures for effective treatment outcomes associated with chronic pain. Further, the recent guidelines in the UK from the National Institute for Health and Care Excellence (NICE) recommend the use of DBS for the treatment of PD.

Browse the full report description UK Neural Implants Market Size, Share & Trends Analysis Report by Product (Deep Brain Stimulation (DCS), Spinal Cord Stimulation (SCS), and Vagus Nerve Stimulation (VNS)), by Application (Chronic Pain, Epilepsy, Parkinson's Disease (PD), and Others (Depression and Other Movement Disorders)), and by End-user (Hospitals, Outpatient Surgery Centers, and Specialized Neurological Centers (SNCs)) Forecast Period (2021-2027) at https://www.omrglobal.com/industry-reports/uk-neural-implants-market

Additionally, owing to such a large patient pool, the market penetration of advanced medical devices such as neural implants is high in the UK. Further, the high penetration of such advanced medical devices paves a significant market opportunity for the global as well as regional players. As a result, vendors are coming up with new marketing and sales strategies to increase sales of highly advanced neural implants. Therefore, the high patient pool, coupled with the availability of advanced devices, is expected to boost the neural implants market in the UK.

Market Coverage

• Market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- by Product, Application, and End-user
• Country Covered- India
• Competitive Landscape- Abbott, Boston Scientific Corporation, LivaNova PLC, Medtronic, and Renishaw plc

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in base year?
• Which segment will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

UK Neural Implants Market Report Segment

By Product 

• Deep Brain Stimulation (DCS)
• Spinal Cord Stimulation (SCS)
• Vagus Nerve Stimulation (VNS)

By Application

• Chronic Pain
• Epilepsy
• Parkinson's Disease (PD)
• Others (Depression and Other Movement Disorders)

By End-user

• Hospitals
• Outpatient Surgery Centers
• Specialized Neurological Centers (SNCs)